Managing Transition in Patients Treated with Growth Hormone

HAUFFA, Berthold P., TOURAINE, Philippe, URQUHART-KELLY, Tanya and KOLEDOVA, Ekaterina (2017). Managing Transition in Patients Treated with Growth Hormone. Frontiers in Endocrinology, 8. (In Press)

[img]
Preview
PDF
Urquhart Kelly Managing Transition in Patients Treated with Growth Hormone.pdf - Published Version
Available under License Creative Commons Attribution.

Download (118kB) | Preview
Official URL: https://www.frontiersin.org/articles/10.3389/fendo...
Link to published version:: 10.3389/fendo.2017.00346

Abstract

Growth hormone (GH) promotes growth in children, but is also essential for bone strength, body composition, metabolic factors, such as lipid profile, and maintenance of quality of life. The Merck KGaA (Germany) funded "360° GH in Europe" meeting, held in Lisbon, Portugal, in June 2016, comprised three sessions entitled "Short Stature Diagnosis and Referral," "Optimizing Patient Management and Adherence," and "Managing Transition." The scientific program covered all stages of pediatric GH treatment, and reported here are the outcomes of the third session of the meeting, which considered transition from pediatric GH treatment to teenage and young adult GH therapy. A large number of patients with chronic diseases, including GH deficiency, drop out of therapy during the transition period. Multiple factors are associated with this, such as lack of understanding of the disease process, insufficient knowledge of treatment options, the patient becoming more independent, and requirement for interaction with a new set of health-care workers. Education regarding disease management and treatment options should be provided from an early age and right through the transition period. However, endocrine specialists will view the transition period differently, depending on whether they are pediatric endocrinologists who mainly deal with congenital diseases, in which auxology is important, or adult endocrinologists who are more concerned with body composition and metabolic factors. View points of both a pediatric and an adult endocrine specialist are presented, together with a case study outlining practical aspects of transition. It was noted in the meeting discussion that having one person to guide a patient through transition from an early age is important, but may be constrained by various factors such as finances, and options will differ by country

Item Type: Article
Departments: Health and Well-being > Nursing and Midwifery
Identification Number: 10.3389/fendo.2017.00346
Depositing User: Carmel House
Date Deposited: 05 Jan 2018 12:36
Last Modified: 06 Jan 2018 07:59
URI: http://shura.shu.ac.uk/id/eprint/18135

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics